Update in palliative management of hormone refractory cancer of prostate
Hormone refractory prostate cancer (HRPC) is an incurable disease and as in the pressure sensitive adhesive era the median survival of patients is increasing, these men increasingly develop symptomatic problems as a result of advanced local and or metastatic disease during their progression to death...
| Main Authors: | , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Medknow Publications
2007
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2721495/ |